SCHEMBL23582263

SCHEMBL23582263

COC(=O)c1cccc(Oc2cccc(Cl)n2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 1.00
PPARG P37231 3/20 0.50
MAPT P10636 2/20 0.50
F2 P00734 3/20 0.48
F10 P00742 3/20 0.48
ALDH1A1 P00352 2/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYSLTR1 Q9Y271 1/20 0.45
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MET P08581 1/20 0.43
ALK Q9UM73 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31357611 1.00 L3MBTL1 (1.00) L3MBTL1PPARGMAPTF2F10
SCHEMBL8050195 0.86 L3MBTL1 (0.75) L3MBTL1MAPTF2F10ALDH1A1
SCHEMBL959081 0.86 L3MBTL1 (0.75) L3MBTL1PPARGF2F10ALDH1A1
SCHEMBL8891193 0.83 L3MBTL1 (0.71) L3MBTL1PPARGMAPTF2F10
SCHEMBL23582356 0.83 L3MBTL1 (0.71) L3MBTL1PPARGMAPTF2F10
SCHEMBL31357669 0.83 L3MBTL1 (0.71) L3MBTL1PPARGMAPTF2F10
SCHEMBL2365602 0.82 L3MBTL1 (0.70) L3MBTL1PPARGMAPTALDH1A1NR1H2
SCHEMBL3456293 0.82 L3MBTL1 (0.69) L3MBTL1PPARGF2F10NR1H2
SCHEMBL2436534 0.80 L3MBTL1 (0.65) L3MBTL1ALDH1A1TP53SMN1; SMN2NPC1
SCHEMBL2365700 0.78 L3MBTL1 (0.64) L3MBTL1PPARGMAPTALDH1A1NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630528-B2 Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof LG CHEM, LTD. (KR) 2026-05-19 US disclosed
EP-4071147-B1 NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF LG CHEMICAL LTD (KR) 2025-03-26 EP disclosed
US-20230078941-A1 NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF LG CHEM, LTD. (KR) 2023-03-16 US disclosed
EP-4071147-A1 NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF Lg Chem, Ltd. (KR) 2022-10-12 EP disclosed
CN-114846013-A Novel aminoaryl derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof 株式会社LG化学 2022-08-02 CN disclosed
WO-2021133035-A1 NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF 주식회사 엘지화학 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230078941-A1 NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF DGAT2, DGAT1, PLAAT2 L3MBTL1 3449/4885PPARG 170/4885MAPT 2601/4885
US-12630528-B2 Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof DGAT2, DGAT1, SOAT2 L3MBTL1 1846/4885PPARG 212/4885MAPT 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.